Cargando…
PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429811/ http://dx.doi.org/10.1097/01.HS9.0000974688.76077.3c |
_version_ | 1785090805148418048 |
---|---|
author | LI, Ziyu Jiang, Qian Zhang, Xiaoshuai Zhang, Yanli Xu, Na Zhu, Huanling Lin, Hai LI, Weiming Du, Xin Liang, Rong LI, Fei Chen, Chunyan Liu, Bingcheng Wang, Xiaodong Yang, Lijie Liu, Zhenfang Pang, Liping Liu, Zhuogang Sun, Xiuli Bai, Yanliang Meng, LI Chen, Suning |
author_facet | LI, Ziyu Jiang, Qian Zhang, Xiaoshuai Zhang, Yanli Xu, Na Zhu, Huanling Lin, Hai LI, Weiming Du, Xin Liang, Rong LI, Fei Chen, Chunyan Liu, Bingcheng Wang, Xiaodong Yang, Lijie Liu, Zhenfang Pang, Liping Liu, Zhuogang Sun, Xiuli Bai, Yanliang Meng, LI Chen, Suning |
author_sort | LI, Ziyu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104298112023-08-17 PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY LI, Ziyu Jiang, Qian Zhang, Xiaoshuai Zhang, Yanli Xu, Na Zhu, Huanling Lin, Hai LI, Weiming Du, Xin Liang, Rong LI, Fei Chen, Chunyan Liu, Bingcheng Wang, Xiaodong Yang, Lijie Liu, Zhenfang Pang, Liping Liu, Zhuogang Sun, Xiuli Bai, Yanliang Meng, LI Chen, Suning Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429811/ http://dx.doi.org/10.1097/01.HS9.0000974688.76077.3c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only LI, Ziyu Jiang, Qian Zhang, Xiaoshuai Zhang, Yanli Xu, Na Zhu, Huanling Lin, Hai LI, Weiming Du, Xin Liang, Rong LI, Fei Chen, Chunyan Liu, Bingcheng Wang, Xiaodong Yang, Lijie Liu, Zhenfang Pang, Liping Liu, Zhuogang Sun, Xiuli Bai, Yanliang Meng, LI Chen, Suning PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY |
title | PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY |
title_full | PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY |
title_fullStr | PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY |
title_full_unstemmed | PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY |
title_short | PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY |
title_sort | pb1968: impacts on outcomes and a predictive model of severe thrombocytopenia in patients with chronic phase chronic myeloid leukemia receiving initial nilotinib-therapy |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429811/ http://dx.doi.org/10.1097/01.HS9.0000974688.76077.3c |
work_keys_str_mv | AT liziyu pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT jiangqian pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT zhangxiaoshuai pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT zhangyanli pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT xuna pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT zhuhuanling pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT linhai pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT liweiming pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT duxin pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT liangrong pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT lifei pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT chenchunyan pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT liubingcheng pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT wangxiaodong pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT yanglijie pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT liuzhenfang pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT pangliping pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT liuzhuogang pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT sunxiuli pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT baiyanliang pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT mengli pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy AT chensuning pb1968impactsonoutcomesandapredictivemodelofseverethrombocytopeniainpatientswithchronicphasechronicmyeloidleukemiareceivinginitialnilotinibtherapy |